AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11246607 — intervention group
Group type: COMPARATOR
Intervention: Control diet (n = 10)
Number of subjects: 20
Study 12017931 — intervention group
Group type: EXPERIMENTAL
Intervention: Arm & Hammer Dental Care (high baking-soda concentration)
Number of subjects: 0
Study 12017931 — intervention group
Group type: EXPERIMENTAL
Intervention: Arm & Hammer PeroxiCare (high baking-soda concentration)
Number of subjects: 0
Study 8316346 — intervention group
Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA) 450-750 mg/day
Number of subjects: 40
Study 8316346 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 3548521 — intervention group
Group type: EXPERIMENTAL
Intervention: Digoxin
Number of subjects: 36
Study 3548521 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 31166248 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal dexamethasone (DEX) implant
Number of subjects: 14
Study 31166248 — intervention group
Group type: COMPARATOR
Intervention: Topical dorzolamide
Number of subjects: 14
Study 31166248 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal DEX implant at Month 6
Number of subjects: 14
Study 31166248 — intervention group
Group type: EXPERIMENTAL
Intervention: Study eyes
Number of subjects: 14
Study 29696669 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary collaborative care
Number of subjects: 0
Study 29696669 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 27958690 — intervention group
Group type: EXPERIMENTAL
Intervention: Granulocyte colony-stimulating factor (G-CSF) 300 µg, two injections prior to BM-MNC transplantation
Number of subjects: 44
Study 27958690 — intervention group
Group type: COMPARATOR
Intervention: Control group (no G-CSF)
Number of subjects: 44
Study 26149149 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand touch training (H group)
Number of subjects: 41
Study 26149149 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term pressure gauge training (G group)
Number of subjects: 41
Study 26149149 — intervention group
Group type: COMPARATOR
Intervention: Comparison between H group and G group for target pressure 60 cmH(2)O
Number of subjects: 41
Study 23193016 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term shiftwork
Number of subjects: 20
Study 23193016 — intervention group
Group type: COMPARATOR
Intervention: Day workers
Number of subjects: 20
Study 22352262 — intervention group
Group type: EXPERIMENTAL
Intervention: Basic treatment
Number of subjects: 130
Study 22352262 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyaluronic acid plus basic treatment
Number of subjects: 130
Study 22352262 — intervention group
Group type: COMPARATOR
Intervention: Healthy gingiva (control group)
Number of subjects: 130
Study 18422632 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic strains (2 x 10(10) CFU)
Number of subjects: 83
Study 18422632 — intervention group
Group type: COMPARATOR
Intervention: Placebo (maltodextrin)
Number of subjects: 83
Study 17186796 — intervention group
Group type: EXPERIMENTAL
Intervention: Desoximetasone 0.25% and tacrolimus 0.1% ointments
Number of subjects: 82
Study 17186796 — intervention group
Group type: COMPARATOR
Intervention: Tacrolimus 0.1% ointment
Number of subjects: 82
Study 15041271 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin-coated stent implantation
Number of subjects: 47
Study 15041271 — intervention group
Group type: COMPARATOR
Intervention: Balloon angioplasty
Number of subjects: 47
Study 10334351 — intervention group
Group type: EXPERIMENTAL
Intervention: Single fraction radiation (750 centigray)
Number of subjects: 27
Study 10334351 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 27
Study 8916055 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical clipping using fronto-temporal and Dolenc approaches
Number of subjects: 54
Study 8916055 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical clipping
Number of subjects: 54
Study 1871540 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisapride 10 mg intravenous injection every 12 hours until the 3rd postoperative day
Number of subjects: 40
Study 1871540 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 7051246 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimethoprim-sulfamethoxazole (TMP-SMZ; 160 mg of TMP and 800 mg of SMZ) twice daily for 21 days
Number of subjects: 147
Study 7051246 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 147
Study 7051246 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimethoprim-sulfamethoxazole (TMP-SMZ)
Number of subjects: 147
Study 29850990 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic (PRP)
Number of subjects: 45
Study 29850990 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLP)
Number of subjects: 45
Study 29850990 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 45
Study 28671090 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol anesthesia
Number of subjects: 1000
Study 28671090 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane anesthesia
Number of subjects: 1000
Study 26363312 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate release oxycodone (20 mg)
Number of subjects: 49
Study 26363312 — intervention group
Group type: COMPARATOR
Intervention: Control group (no drug administered)
Number of subjects: 49
Study 23608249 — intervention group
Group type: EXPERIMENTAL
Intervention: Lowest vitamin D quartile (1-15.9 ng/ml)
Number of subjects: 936
Study 21915572 — intervention group
Group type: EXPERIMENTAL
Intervention: PTH 1-84 (100 µg once daily)
Number of subjects: 65
Study 21915572 — intervention group
Group type: COMPARATOR
Intervention: Control (no PTH 1-84)
Number of subjects: 65
Study 21915572 — intervention group
Group type: EXPERIMENTAL
Intervention: PTH 1-84
Number of subjects: 65
Study 21915572 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 65
Study 19820390 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemoradiation
Number of subjects: 90
Study 17120865 — intervention group
Group type: EXPERIMENTAL
Intervention: Video Inter‐Active (VIA) method; duration 5 weeks
Number of subjects: 0
Study 14687899 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrate therapy
Number of subjects: 0
Study 14687899 — intervention group
Group type: COMPARATOR
Intervention: No-drug treatment
Number of subjects: 0
Study 12151286 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Remediation Therapy (CRT)
Number of subjects: 0
Study 12151286 — intervention group
Group type: COMPARATOR
Intervention: Control therapy
Number of subjects: 0
Study 9706934 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mL of 0.125% bupivacaine
Number of subjects: 42
Study 9706934 — intervention group
Group type: COMPARATOR
Intervention: 60 mL of isotonic sodium chloride solution (placebo)
Number of subjects: 42
Study 7788912 — intervention group
Group type: EXPERIMENTAL
Intervention: 17 beta-Estradiol (2.5 micrograms)
Number of subjects: 16
Study 7788912 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate (1 mg)
Number of subjects: 16
Study 7788912 — intervention group
Group type: COMPARATOR
Intervention: Intracoronary placebo
Number of subjects: 16
Study 1693325 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextran prophylaxis
Number of subjects: 176
Study 371340 — intervention group
Group type: EXPERIMENTAL
Intervention: i.v. tolbutamide after peroral glucose load
Number of subjects: 16
Study 371340 — intervention group
Group type: EXPERIMENTAL
Intervention: i.v. glipizide
Number of subjects: 16
Study 6134490 — intervention group
Group type: EXPERIMENTAL
Intervention: Alclofenac 1 g 3 or 4 times daily
Number of subjects: 27
Study 6134490 — intervention group
Group type: COMPARATOR
Intervention: Gold injections 50 mg weekly intramuscularly to 1 g then 50 mg monthly
Number of subjects: 27
Study 31141104 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 3037
Study 31141104 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel
Number of subjects: 3037
Study 31141104 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel (reduced metabolizer status)
Number of subjects: 3037
Study 31141104 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel (prestipulated switching)
Number of subjects: 3037
Study 29350663 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored medical support including translated booklets, weekly visits, family-guides, and interpreter-supported clinic visits (Group 1)
Number of subjects: 40
Study 29350663 — intervention group
Group type: COMPARATOR
Intervention: Standard protocol (Group 2)
Number of subjects: 40
Study 29350663 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored medical support (Group 1)
Number of subjects: 40
Study 27126239 — intervention group
Group type: EXPERIMENTAL
Intervention: Active rESW
Number of subjects: 60
Study 27126239 — intervention group
Group type: COMPARATOR
Intervention: Placebo rESW
Number of subjects: 60
Study 24293282 — intervention group
Group type: EXPERIMENTAL
Intervention: Community pharmacy‐based intervention for improving adherence to antihypertensive medication
Number of subjects: 0
Study 24293282 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported Morisky scale
Number of subjects: 0
Study 24293282 — intervention group
Group type: EXPERIMENTAL
Intervention: Dispensing records
Number of subjects: 0
Study 22182667 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-focused treatment for prodromal youth (6-month, 18-session intervention)
Number of subjects: 0
Study 22182667 — intervention group
Group type: COMPARATOR
Intervention: Enhanced care control intervention (3-session psychoeducational intervention)
Number of subjects: 0
Study 21510531 — intervention group
Group type: EXPERIMENTAL
Intervention: Buffy coat (mesenchymal stem cell concentrate) injection along with arthroscopic debridement
Number of subjects: 50
Study 21510531 — intervention group
Group type: COMPARATOR
Intervention: Arthroscopic debridement alone
Number of subjects: 50
Study 18811927 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led case management home care model
Number of subjects: 0
Study 18811927 — intervention group
Group type: COMPARATOR
Intervention: Conventional home care model
Number of subjects: 0
Study 16135173 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous theophylline (200 mg in 200 mL saline) for 2 hours
Number of subjects: 22
Study 16135173 — intervention group
Group type: COMPARATOR
Intervention: Saline (200 mL)
Number of subjects: 22
Study 12424551 — intervention group
Group type: EXPERIMENTAL
Intervention: Stimulant medications (6-month trial)
Number of subjects: 0
Study 12424551 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 10529069 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline (50-100 mg/day)
Number of subjects: 286
Study 10529069 — intervention group
Group type: COMPARATOR
Intervention: Fluoxetine (20-40 mg/day)
Number of subjects: 286
Study 7671978 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose methylprednisolone (1 g MP administered i.v. daily for 5 days followed by oral prednisone tapering over 4 days)
Number of subjects: 35
Study 7671978 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study 2074407 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard lateral condensation technique
Number of subjects: 60
Study 2074407 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm lateral condensation technique 1
Number of subjects: 60
Study 2074407 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm lateral condensation technique 2
Number of subjects: 60
Study 2074407 — intervention group
Group type: COMPARATOR
Intervention: Negative control (4 teeth)
Number of subjects: 60
Study 2074407 — intervention group
Group type: COMPARATOR
Intervention: Positive control (2 teeth)
Number of subjects: 60
Study 6786953 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25 mg copper daily
Number of subjects: 28
Study 6786953 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.05 mg copper daily
Number of subjects: 28
Study 6786953 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.85 mg copper daily
Number of subjects: 28
Study 6786953 — intervention group
Group type: COMPARATOR
Intervention: 1 mg copper daily (fixed dose)
Number of subjects: 28
Study 6786953 — intervention group
Group type: EXPERIMENTAL
Intervention: Copper requirements for total parenteral nutrition
Number of subjects: 28
Study 6786953 — intervention group
Group type: EXPERIMENTAL
Intervention: Copper requirements for total parenteral nutrition with diarrhea or increased fluid loss
Number of subjects: 28
Study 6786953 — intervention group
Group type: EXPERIMENTAL
Intervention: Urinary copper excretion
Number of subjects: 28
Study 6786953 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma copper levels
Number of subjects: 28
Study 6786953 — intervention group
Group type: EXPERIMENTAL
Intervention: Copper infused in excess of requirements
Number of subjects: 28
Study 30971277 — intervention group
Group type: EXPERIMENTAL
Intervention: SponDT scoring system
Number of subjects: 296
Study 27579992 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-delivered problem-solving treatment (PST)
Number of subjects: 356
Study 27579992 — intervention group
Group type: COMPARATOR
Intervention: Education-only (EO)
Number of subjects: 356
Study 25347016 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-administered coping skills training program (iCST)
Number of subjects: 89
Study 25347016 — intervention group
Group type: COMPARATOR
Intervention: Delayed treatment control (DTC)
Number of subjects: 89
Study 25050589 — intervention group
Group type: EXPERIMENTAL
Intervention: Submicron diclofenac 35 mg tid
Number of subjects: 0
Study 25050589 — intervention group
Group type: EXPERIMENTAL
Intervention: Submicron diclofenac 35 mg bid
Number of subjects: 0
Study 25050589 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 21466563 — intervention group
Group type: EXPERIMENTAL
Intervention: Priming materialism
Number of subjects: 155
Study 21466563 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to materialistic media
Number of subjects: 155
Study 18439584 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH analog for 3 months before surgery
Number of subjects: 20
Study 18439584 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 3 months before surgery
Number of subjects: 20
Study 17326737 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibration (of the wrist extensor tendons to elicit the illusion of wrist flexion)
Number of subjects: 22
Study 17326737 — intervention group
Group type: EXPERIMENTAL
Intervention: Sham (vibration of the ulna styloid)
Number of subjects: 22
Study 17326737 — intervention group
Group type: EXPERIMENTAL
Intervention: Active flexion
Number of subjects: 22
Study 17326737 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive flexion
Number of subjects: 22
Study 17326737 — intervention group
Group type: COMPARATOR
Intervention: Control (no stimulus)
Number of subjects: 22
Study 15200748 — intervention group
Group type: EXPERIMENTAL
Intervention: Levocetirizine 5 mg od
Number of subjects: 100
Study 15200748 — intervention group
Group type: EXPERIMENTAL
Intervention: Loratadine 10 mg od
Number of subjects: 100
Study 15200748 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 11450816 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamotrigine
Number of subjects: 28
Study 11450816 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 10068180 — intervention group
Group type: EXPERIMENTAL
Intervention: Dorsoventral one-stage instrumentation with CDI and anterior grafting (group 1)
Number of subjects: 72
Study 10068180 — intervention group
Group type: COMPARATOR
Intervention: Anterior CDH instrumentation in combination with anterior grafting (group 2)
Number of subjects: 72
Study 8177478 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flux cellulose acetate membrane (CA-HF800-E, Diaphan)
Number of subjects: 0
Study 8177478 — intervention group
Group type: COMPARATOR
Intervention: Cellulose triacetate (CTA)
Number of subjects: 0
Study 8177478 — intervention group
Group type: COMPARATOR
Intervention: Polysulphone
Number of subjects: 0
Study 3554963 — intervention group
Group type: EXPERIMENTAL
Intervention: Fat-containing breakfasts (butter or peanut butter)
Number of subjects: 0
Study 3554963 — intervention group
Group type: COMPARATOR
Intervention: Isocaloric larger carbohydrate meal
Number of subjects: 0
Study 31636000 — intervention group
Group type: EXPERIMENTAL
Intervention: 2D Gaussian probability density function of rectal motion and wall thickness (2D pdfM&TW)
Number of subjects: 587
Study 31636000 — intervention group
Group type: EXPERIMENTAL
Intervention: Probability density functions of rectal deformation (DW), rectal dose distribution (RM), and changes in rectal wall thickness (TW)
Number of subjects: 587
Study 31636000 — intervention group
Group type: EXPERIMENTAL
Intervention: Gaussian mixture distributions for rectal wall thickness
Number of subjects: 587
Study 30677319 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunflower inbred lines (ILs)
Number of subjects: 137
Study 30677319 — intervention group
Group type: EXPERIMENTAL
Intervention: Broad-sense heritability estimates
Number of subjects: 137
Study 26527863 — intervention group
Group type: EXPERIMENTAL
Intervention: Single oral doses of dicloxacillin sodium (0.25, 0.5, 1.0, and 2.0 g)
Number of subjects: 16
Study 26527863 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple oral doses of dicloxacillin sodium (0.25 or 0.5 g every 6 hours for 3 days)
Number of subjects: 16
Study 23218455 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeinated coffee
Number of subjects: 10
Study 23218455 — intervention group
Group type: COMPARATOR
Intervention: Decaffeinated coffee
Number of subjects: 10
Study 21444887 — intervention group
Group type: EXPERIMENTAL
Intervention: REV strategy
Number of subjects: 2364
Study 21444887 — intervention group
Group type: COMPARATOR
Intervention: MED strategy
Number of subjects: 2364
Study 19270315 — intervention group
Group type: EXPERIMENTAL
Intervention: Total arterial revascularization (TAR)
Number of subjects: 331
Study 19270315 — intervention group
Group type: COMPARATOR
Intervention: Conventional revascularization (CR)
Number of subjects: 331
Study 16719030 — intervention group
Group type: EXPERIMENTAL
Intervention: AFO (ankle-foot orthosis)
Number of subjects: 28
Study 15579913 — intervention group
Group type: EXPERIMENTAL
Intervention: Ifosfamide and cisplatin
Number of subjects: 361
Study 15579913 — intervention group
Group type: EXPERIMENTAL
Intervention: Ifosfamide, cisplatin, and taxanes (paclitaxel or docetaxel)
Number of subjects: 361
Study 11132503 — intervention group
Group type: EXPERIMENTAL
Intervention: Wand injections
Number of subjects: 62
Study 11132503 — intervention group
Group type: COMPARATOR
Intervention: Traditional palatal injection
Number of subjects: 62
Study 11132503 — intervention group
Group type: COMPARATOR
Intervention: Traditional buccal injection
Number of subjects: 62
Study 9358675 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiarrhythmic agents for primary prevention of first episodes in high-risk patients
Number of subjects: 0
Study 9358675 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiarrhythmic agents for secondary prevention in patients who have survived an episode of VT or VF
Number of subjects: 0
Study 9358675 — intervention group
Group type: EXPERIMENTAL
Intervention: Identification of high-risk patients for primary prevention
Number of subjects: 0
Study 7903545 — intervention group
Group type: EXPERIMENTAL
Intervention: Vecuronium 100 micrograms/kg
Number of subjects: 90
Study 7903545 — intervention group
Group type: EXPERIMENTAL
Intervention: Pancuronium 100 micrograms/kg
Number of subjects: 90
Study 7903545 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixture of vecuronium (50 micrograms/kg) and pancuronium (50 micrograms/kg)
Number of subjects: 90
Study 7903545 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 90
Study 2856769 — intervention group
Group type: EXPERIMENTAL
Intervention: Felodipine
Number of subjects: 15
Study 2856769 — intervention group
Group type: COMPARATOR
Intervention: Minoxidil
Number of subjects: 15
Study 30832609 — intervention group
Group type: EXPERIMENTAL
Intervention: LoChro-Care intervention (7 to 16 contacts with chronic care managers within 12 months)
Number of subjects: 606
Study 30832609 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 606
Study 29251010 — intervention group
Group type: EXPERIMENTAL
Intervention: Abaloparatide (80 µg/day) for 18 months followed by Alendronate (70 mg/week) for 6 months
Number of subjects: 0
Study 29251010 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 18 months followed by Alendronate (70 mg/week) for 6 months
Number of subjects: 0
Study 26351087 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupi Yishen formula (BYF)
Number of subjects: 554
Study 26351087 — intervention group
Group type: COMPARATOR
Intervention: Losartan 100 mg daily
Number of subjects: 554
Study 23910392 — intervention group
Group type: EXPERIMENTAL
Intervention: Workshop and resources (WS+)
Number of subjects: 161
Study 23910392 — intervention group
Group type: EXPERIMENTAL
Intervention: WS+ and computer assisted training (WS+/CAT)
Number of subjects: 161
Study 23910392 — intervention group
Group type: EXPERIMENTAL
Intervention: WS+/CAT and supervisory support (WS+/CAT/SS)
Number of subjects: 161
Study 20855349 — intervention group
Group type: EXPERIMENTAL
Intervention: Psilocybin (1-4 oral doses, 45-315 µg/kg body weight)
Number of subjects: 110
Study 20855349 — intervention group
Group type: EXPERIMENTAL
Intervention: Psilocybin (high doses)
Number of subjects: 110
Study 20855349 — intervention group
Group type: EXPERIMENTAL
Intervention: Psilocybin
Number of subjects: 110
Study 20855349 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal support during adverse reactions
Number of subjects: 110
Study 20046656 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based care management (IBCM) program for diabetes for 1 year
Number of subjects: 104
Study 20046656 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 104
Study 20046656 — intervention group
Group type: EXPERIMENTAL
Intervention: IBCM with sustained usage
Number of subjects: 104
Study 20046656 — intervention group
Group type: EXPERIMENTAL
Intervention: Changes in HbA1c
Number of subjects: 104
Study 17209189 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily multiple-micronutrient foodLET providing the Recommended Nutrient Intake (RNI) (DMM)
Number of subjects: 133